Global Pediatric Vaccine Market to be Worth around USD 56.28 billion by 2025 – ZMR

Zion Market Research has published a new report titled “Pediatric Vaccine Market By Vaccine Type (Monovalent and Multivalent), By Administration Method (Oral, Intramuscular, and Subcutaneous), By Disease Type (Meningococcal Disease, Hepatitis, Influenza, Polio, Pneumococcal Disease, DTP, MMR, Dengue, Rotavirus, HPV, Varicella, Herpes Zoster, and Others), By Technology (Recombinant Vaccines, Inactivated Vaccines, Conjugate Vaccines, Toxoid Vaccines, and Live Attenuated Vaccines), and By End-User (Hospitals, Healthcare Providers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global pediatric vaccine market was approximately USD 27.45 billion in 2018 and is expected to generate around USD 56.28 billion by 2025, at a CAGR of around 10.8% between 2019 and 2025.

Pediatric vaccines protect children from complications and serious illnesses, which could lead to paralysis, brain damage, amputations, and even death. The growing prevalence of preventable diseases occurs when parents do not administer vaccinations on a timely basis. Organizations like the American Academy of Family Physicians, the American Academy of Pediatrics, and the Centers for Disease Control and Prevention administer the regulations and schedules for recommended vaccinations. Vaccine-preventable diseases, such as whooping cough, measles, and mumps, affect millions of children globally and can even lead to deaths, long-term hospitalizations, and severe paralysis if left untreated. The immune system, which is composed of organs, cells, fluids, and glands, recognizes the germs, called antigens, and produces large Y-shaped proteins called antibodies to fight them.

For example, mumps vaccine contains the mumps virus. The antigens in these vaccines are either weakened or killed, to prevent the disease from infecting the body further. The global pediatric vaccine market is driven by increasing geriatric base, rising prevalence of infectious diseases, and growing disposable income of the global population. The rising number of immunization programs globally and the increasing awareness about the importance of preventive care during childhood are also fueling this market.

Get Free Sample Report for more Insights – https://www.zionmarketresearch.com/sample/pediatric-vaccine-market

The global pediatric vaccine market is divided based on disease type, vaccine type, administration method, technology, and end-user. By vaccine type, the market includes monovalent and multivalent vaccines. Monovalent vaccines develop a rapid immune response and are more stable than multivalent vaccines. Multivalent vaccines are showing improved growth due to the development of tetravalent, hexavalent, and pentavalent vaccines. Based on technology,  the market comprises recombinant vaccines, inactivated vaccines, conjugate vaccines, toxoid vaccines, and live attenuated vaccines. Conjugate vaccines have the maximum demand, due to the rising incidences of meningococcal and pneumococcal infections. The disease type segment consists of dengue, pneumococcal disease, hepatitis, MMR (measles, mumps, and rubella), varicella, polio, influenza, DTP, herpes zoster, rotavirus, human papilloma virus, meningococcal disease, and others. The method segment of the pediatric vaccine market includes oral, subcutaneous, and intramuscular. Hospitals, healthcare providers, and others are the various end-user of the pediatric vaccine market.

North America is witnessed to be a significant contributor to the pediatric vaccine market globally, due to the increasing number of hospitals, developing insurance sector, and favorable government regulations. The European pediatric vaccine market is growing owing to the ease of operability, efficient resource planning, presence of a large number of pharmaceutical companies, and rising government funding. All this makes facilitates quick and easy sourcing of vaccines. The Asia Pacific pediatric vaccine market will register the highest CAGR in the future, owing to the rapidly growing pediatric vaccine demand in India and Singapore. Latin America is projected to exhibit moderate growth in the pediatric vaccine market over the forecast timeframe.

Browse Full TOC of this Research Report – https://www.zionmarketresearch.com/toc/pediatric-vaccine-market

Some key players operating in the global pediatric vaccine market are Mitsubishi Tanabe Pharma, Astellas Pharma, Johnson & Johnson, Pfizer, CSL Limited, GlaxoSmithKline, Serum Institute of India, Panacea Biotec, Daiichi Sankyo, and Merck.

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.